PATENTS

Ask any patent practitioner the hardest territories in which to pursue pharmaceutical patents and they will probably mention Brazil. Idiosyncrasies in the way Brazil examines patent applications have caused huge delays in prosecution, as well as complaints of unfair rejections and even bias against foreign applicants.